Xtx Topco LTD Genprex, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.37 - $1.04 $7,162 - $20,133	-19,359 Reduced 48.82%	20,298 $8,000
Q2 2023 Aug 14, 2023	BUY	$0.74 - $1.1 $29,346 - $43,622	39,657 New	39,657 $37,000
Q3 2021 Nov 12, 2021	SELL	$2.59 - $3.36 $61,134 - $79,309	-23,604 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.11 - $4.87 $73,408 - $114,951	23,604 New	23,604 $79,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $112M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.